Delivery Order SPE2DE21D7020-SPE2D625F2EVT
- Not listed
- Boston Scientific Corp has been awarded a delivery order valued at $7,900.80 by the Defense Health Agency's Medical Supply Chain for the supply of 24mm NG synthetic material. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 11, 2025, following the award date of August 4, 2025. Performance will be executed at the company's facility in Marlborough, Massachusetts. This award was not designated as a...
- Boston Scientific Corp has been awarded a delivery order valued at $15,445.80 by the Defense Health Agency's Medical Supply Chain for the supply of 24mm NG synthetic medical equipment. The contract, awarded on August 18, 2025, with an ultimate completion date of August 25, 2025, utilizes fixed price pricing with economic price adjustment terms and carries no set-aside designation. Performance will be conducted at Boston Scientific's facility in Marlborough, Massachusetts. As a leading global...
- Boston Scientific Corp has been awarded a delivery order valued at $6,437.48 for medical supply provision under the Defense Health Agency's Medical Supply Chain program. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, carries an ultimate completion date of June 16, 2025, and was executed on June 9, 2025. The order involves the supply of NG synthetic material in 38mm configuration and will be performed at Boston Scientific's facility in...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $7,669.40 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as 4568924698 for NG synthetic MR US 38MM medical supplies, represents a non-competitive award with no set-aside designation. Boston Scientific will perform this work at its...
- Boston Scientific Corp has been awarded a delivery order valued at $2,527.50 by the Defense Health Agency's Medical Supply Chain for the supply of 12mm synthetic material medical products. The contract, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, operates under a fixed-price arrangement with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No set-aside designation was applied to...
- The U.S. Defense Health Agency's Medical Supply Chain has awarded a delivery order valued at $2,995.04 to Boston Scientific Corp for NG SYN MR US 28MM supplies. The contract was awarded on July 21, 2025, with an ultimate completion date of July 28, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This is a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, meaning it was awarded through open...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp has been awarded a delivery order valued at $8,105.25 for the supply of NG SYN MR US 16MM medical devices, with an ultimate completion date of August 5, 2025. This fixed-price contract with economic price adjustment is not set aside for any specific business type, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where the company manufactures innovative medical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2EVTDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $1,975.20 by the Defense Health Agency's Medical Supply Chain division for the delivery of NG synthetic MR US 12MM medical supplies. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 8, 2025. The award was issued on August 29, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. Performance will be conducted at the company's facility in Marlborough, Massachusetts. This delivery order represents a continuation of Boston Scientific's substantial engagement with the Defense Health Agency's medical supply chain operations. As a leading global medical technology company, Boston Scientific serves as a prime contractor across multiple federal healthcare agencies, providing critical medical devices and technologies including cardiovascular interventions, neurostimulation systems, stents, catheters, and diagnostic equipment. The company maintains significant indefinite delivery vehicles with the DHA and other federal health agencies, positioning it as a strategic supplier of specialized medical technologies to the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/29/25 |